Catalyst Wire Dossier Catalyst Wire Dossier

Zidovudine 300 mg tablets, USP

Zidovudine · Ranbaxy Laboratories Limited
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Zidovudine 300 mg tablets, USP, covering 2008-10-24 to 2008-10-24. Get the full timeline:

Most recent: Clinical Trial Update: Bioequivalence Study of Zidovudine 300 mg Tablets, USP Under Fed Conditions [NA]

See pricing